Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Boston University School of Medicine designates this live activityfor a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity

End of Life Education Statement

This program meets the criteria of the Massachusetts Board of Registration in Medicine for end of life care education.

Risk Management

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

Objectives

To discuss standards of head and neck cancer diagnosis
To explain multidisciplinary management of head and neck cancer
To apply latest head and neck cancer management principles to one’s practice including end of life issues and palliative care options

Target Audience

Attending Physicians including; Radiology, Radiation Oncology, Dentistry, Medical Oncology, Surgery, Otolaryngology. Residents, Speech Pathologists, and Fellows.

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement:

Waleed Ezzat, Co-Course Director and Speaker, has no relevant financial relationships to disclose.

Andrew Salama, Co-Course Director, has no relevant financial relationships to disclose.

Sakina Flint, Program Manager, has no relevant financial relationships to disclose.

Faculty disclosure of off-label use:

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.